Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of the Renin-Angiotensin System in Pediatric Primary Hypertension (PHRAS)

NCT03310684 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT03310684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03310684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of the Renin-Angiotensin System in Pediatric Primary Hypertension (PHRAS)
Lead sponsor
Wake Forest University Health Sciences
Phase
Observational
Overall status
Completed
Start date
December 3, 2018
Completion date
April 26, 2023
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric disorder, pediatric obesity, primary hypertension